Poly Medicure Limited (NSE:POLYMED)
2,236.20
+24.95 (1.13%)
Mar 28, 2025, 3:29 PM IST
Poly Medicure Revenue
Poly Medicure had revenue of 4.24B INR in the quarter ending December 31, 2024, with 24.92% growth. This brings the company's revenue in the last twelve months to 16.07B, up 23.19% year-over-year. In the fiscal year ending March 31, 2024, Poly Medicure had annual revenue of 13.76B with 23.36% growth.
Revenue (ttm)
16.07B
Revenue Growth
+23.19%
P/S Ratio
n/a
Revenue / Employee
2.55M
Employees
6,300
Market Cap
227.18B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 13.76B | 2.61B | 23.36% |
Mar 31, 2023 | 11.15B | 1.92B | 20.82% |
Mar 31, 2022 | 9.23B | 1.37B | 17.37% |
Mar 31, 2021 | 7.86B | 992.31M | 14.44% |
Mar 31, 2020 | 6.87B | 764.14M | 12.51% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 267.20B |
Mankind Pharma | 116.41B |
Apollo Hospitals Enterprise | 211.46B |
Zydus Lifesciences | 222.47B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |
Poly Medicure News
- 7 weeks ago - Poly Medicure Ltd (BOM:531768) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - GuruFocus
- 7 weeks ago - Q3 2025 Poly Medicure Ltd Earnings Call Transcript - GuruFocus
- 2 months ago - Poly Medicure Q3 FY25 Results: Revenue up 25% YoY to Rs 424 crore, net profit jump 31% YoY - Business Upturn
- 2 months ago - Poly Medicure announces Joint Venture for solar power project - Business Upturn
- 4 months ago - Top market losers today: ZF Commercial India plunges 12.85%, GE Vernova down 5.00%, Prestige Estates drops 3.59% in morning trade - Business Upturn
- 5 months ago - Poly Medicure Q2 Results: Revenue surges 9.15% YoY to ₹420.01 crore, Net Profit surges 40.64% YoY - Business Upturn
- 5 months ago - Stock market update: Q2 FY25 results today for Sumitomo Chemical, Pfizer, Poly Medicure, Firstsource, Anant Raj, CAMS, Kalpatru, Railtel and more - Business Upturn
- 6 months ago - Top gainers in today’s market: Aptus surges 9.20%, BSE up 7.80%, Poly Medicure jumps 6.24%, CDSL rises 5.26% - Business Upturn